KXIN’s 199% Surge Sparks Small-Cap Rally Led by Biotech & Digital-Asset Stocks
By ATTN Desk · Editorial oversight: Sean Han
Daily Market Recap – 2025-11-17
The U.S. small-cap and micro-cap segment powered higher on November 17, with all 19 tracked tickers posting double-digit gains. Biotechnology names and digital-asset-themed issuers led the charge, while heavy trading volume underscored broad retail and institutional interest. Below is a summary of key price moves and volume patterns.
Movers and Shakers
| Ticker | ATTN Price | Current Price | Volume | Price Change % |
|---|---|---|---|---|
| AMIX | 0.71 | 1.16 | 164,064,982 | 62.82% |
| WTO | 0.02 | 0.0298 | 506,916,003 | 32.71% |
| SGML | 6.46 | 8.005 | 26,819,387 | 23.91% |
| SOND | 0.08 | 0.1159 | 5,348,847 | 37.90% |
| KXIN | 0.09 | 0.2835 | 146,495,180 | 199.28% |
| GLMD | 0.70 | 1.0601 | 54,344,695 | 50.97% |
| CGTL | 0.60 | 0.8195 | 8,096,683 | 35.92% |
| IVVD | 2.17 | 2.85 | 14,915,247 | 31.19% |
| ONEG | 1.46 | 2.227 | 1,043,185 | 52.48% |
| UONEK | 0.36 | 0.6298 | 8,929,851 | 75.99% |
| TAIT | 0.91 | 1.145 | 648,127 | 26.12% |
| EPSM | 1.02 | 1.41 | 350,687 | 37.96% |
| APLT | 0.16 | 0.286 | 183,562,742 | 80.91% |
| SSP | 3.31 | 4.28 | 8,308,937 | 29.45% |
| DGNX | 10.67 | 13.39 | 977,414 | 25.43% |
| RPGL | 0.28 | 0.53 | 1,952,308 | 86.77% |
| CYCU | 3.45 | 4.52 | 974,162 | 31.21% |
| PACS | 11.85 | 15.675 | 7,452,341 | 32.34% |
| ANVS | 1.75 | 2.9701 | 30,645,577 | 69.79% |
Market Trends and Patterns
Biotechnology and clinical-stage drug developers again captured traders’ attention, with ANVS (+69.8%), GLMD (+51.0%) and ONEG (+52.5%) all seeing notable rallies on trial and regulatory catalysts. Equally striking was the surge in digital-asset and incentive-driven names: KXIN soared almost 200%, powered by an equity incentive plan and a new digital asset management unit, while UONEK jumped 76.0% amid increased retail interest in specialty lending platforms.
Volume concentrations were considerable. WTO led with over 506 million shares traded, followed by APLT at 183 million and AMIX at 164 million. High turnover was also evident in KXIN (146 million) and GLMD (54 million), signaling broad participation in the session’s most volatile names.
Across the board, every ticker posted a gain exceeding 20%. Even the more established small-caps—DGNX (+25.4%), SGML (+23.9%) and PACS (+32.3%)—registered strong upticks, reflecting a risk-on attitude among investors in the final quarter of the year.
Biotechnology by Louis Reed
Significant Moves
- KXIN: The standout leader at +199.3%, on news of a 1-for-30 reverse split, 6 million incentive shares and a strategic push into digital-asset management.
- RPGL: Up 86.8% following chatter about potential 2025 profitability and a strengthening cash position post-reverse split.
- APLT: Shares climbed 80.9% after Phase 3 govorestat data readouts and an anticipated NDA filing late in 2025.
- UONEK & ONEG: Both jumped on investor enthusiasm for fintech-adjacent offerings, with UONEK at +76.0% and ONEG at +52.5%.
TL;DR
- Broad-based small-cap rally: all 19 tickers up at least 20%.
- KXIN leads with a 199.3% surge on equity incentives and digital-asset strategy.
- Heavy volume in WTO (507 M), APLT (184 M) and AMIX (164 M) underscores retail interest.
- Biotech catalysts drive double-digit gains in ANVS, GLMD and ONEG.
- Market tone remains risk-on as year-end approaches.